This article was written byFollowDaniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter…
Gideon talks to Jens Stoltenberg, Nato's former secretary-general, about Ukraine and Europe's strategic priorities after recent scathing criticism from US…
No Risk, No Reward Lending, at its core, is a generally uncomplicated business: companies borrow…
Introduction Shares of 1stDibs (NASDAQ:DIBS) have fallen 18% YTD. Despite the fact that the company…
Receive free Football updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
With interest rates sky-high and investors expecting more volatility throughout the end of the year,…
Receive free German economy updatesWe’ll send you a myFT Daily Digest email rounding up the…
Twin Disc (NASDAQ:TWIN) recently reaffirmed its medium-term targets, including future gross margin close to 30%…
Receive free Yevgeny Prigozhin updatesWe’ll send you a myFT Daily Digest email rounding up the…
Exelixis (NASDAQ:EXEL) has made great progress in advancing its drug known as CABOMETYX for the…
Deals and Financings China’s drug distributors are in the hunt to acquire Poland’s Neuca, a…
Receive free Interiors updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Editor's note: Seeking Alpha is proud to welcome X's Industry Analysis as a new contributor.…
Receive free Zimbabwe updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
I was very lucky with the timing on my last article on Curaleaf (OTCPK:CURLF), when…
Introduction Xeris Biopharma (NASDAQ:XERS), a biopharmaceutical firm, focuses on enhancing patient lives with innovative therapies.…
After experiencing whopping returns in the past few years, shareholders of Carlyle Secured Lending Inc.…
YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!
Sign in to your account
